The Operative Sentence

A reading room for the primary documents behind operating-room safety and surgical fluid waste.

Published
2026-08-06
Last reviewed
2026-08-06
Next review
2027-08-06
Written by
Zane Hitchcox, publisher — not a clinician; has never worked in an operating room
Review status
Sources verified against primary text. Not clinically reviewed.
Disclosure
No financial relationship with any manufacturer, distributor, waste contractor or trade body. No advertising, no affiliate links, no sponsored content.
Version
1.0

The Operative Sentence

What published guidance says happens after a blood or body-fluid splash to the eye

A source-by-source account of what each retrieved guideline says, and of what the bloodborne pathogens standard obliges an employer to provide and pay for.

The Operative Sentence is an independent reference publication. It is not affiliated with BioDrain Medical, Inc., Axe Compute Inc., DeRoyal Industries, Inc. or any manufacturer, and it sells, services and recommends nothing. This page describes what published regulations, guidelines and studies say. It is not legal advice, not clinical advice, and not a substitute for your facility's exposure control plan, your state's rules or your sewer authority's ordinance. Nobody who writes these pages has worked in an operating room. This publication is not a standards body and nothing here is a standard, a guideline or a government publication.

Documents cited in this article

If this has just happened

If this has just happened, contact your occupational health service or an emergency department now. This page is a record of what published guidance says and cannot tell you what to do.

In brief

  • Once an exposure incident is reported, 29 CFR 1910.1030(f)(3) requires the employer to make a confidential medical evaluation and follow-up immediately available, and (f)(1)(ii)(A) requires it at no cost to the employee.1
  • The standard's definition of an exposure incident turns on contact, not on volume. It sets no minimum quantity and no threshold below which an eye splash stops counting.1
  • The current federal guideline for occupational HIV exposure is the 2025 US Public Health Service update, not the 2013 document many pages still reproduce; among the things it changed is a shortened schedule of follow-up HIV testing.4
  • We found no document in this set that states how long an eye should be irrigated. Four of them say to flush or irrigate; none gives a duration, a volume or a temperature.178
  • Blood may reach the eye more often than anyone notices: in one oculofacial series, blood was detected on 61% of 331 protective eye shields worn across 131 cases, while 2% of splatters were recognised during surgery. One small single-specialty study; low certainty.11

What this page is, and what it is not

This is a citational brief. For each document we retrieved, it sets out what that document says about washing, reporting, testing, prophylaxis and follow-up, quoted and dated. It does not combine them into a sequence or a checklist. That refusal is the design of the page: a compressed schedule assembled by a publisher who has never managed an exposure would be clinical instruction to a frightened person, in our voice rather than the guideline's.

Everything below was pulled as raw text from the document itself on 2026-08-06 — the GPO XML of the Code of Federal Regulations, the agency PDFs, the HTML of the pages named. Nothing here is transcribed from a summary of a document.

This is a survey of published federal regulation and national guidance, not advice about a facility. Twenty-nine OSHA State Plans run their own standards, which may be more stringent than the federal text quoted here, and your facility's exposure control plan is separately binding. Check both.

What counts as an exposure incident

The recurring question in the nursing forums is whether a small splash is "a real exposure". The standard answers with a definition, and the definition has no quantity in it.

29 CFR § 1910.1030(b) · definition of “Exposure Incident”, 2024 annual edition of the CFR

Exposure Incident means a specific eye, mouth, other mucous membrane, non-intact skin, or parenteral contact with blood or other potentially infectious materials that results from the performance of an employee's duties.

Eye contact is named first, and it is the only route on that list that needs no wound and no needle. The qualifiers the definition does carry are specific — a particular contact, arising from duties — and the material, blood or other potentially infectious materials, which the same paragraph defines by listing the fluids it covers.1 Nothing in it scales with volume, and nothing in it requires a witness.

What the employer owes once an exposure is reported

The duty in paragraph (f) is triggered by a report, and it is written in the imperative.

Following a report of an exposure incident, the employer shall make immediately available to the exposed employee a confidential medical evaluation and follow-up, including at least the following elements:

What it says

A report starts the clock. What follows must be immediate, confidential, and at least the six elements the paragraph then enumerates: documentation of route and circumstances; identification and testing of the source individual; collection and testing of the employee's blood; post-exposure prophylaxis when medically indicated; counselling; and evaluation of reported illnesses.1

What it does not say

It does not say who the employee reports to, in what form, or within what period. It does not name a test, an interval or a drug — those come from the Public Health Service documents the standard points at, by reference rather than by name. And it does not say what happens if the employee does not report.

The conditions attached to that evaluation are in (f)(1)(ii), and one of them is the hinge on which the rest of this page turns.

29 CFR § 1910.1030(f)(1)(ii)–(iii) · 2024 annual edition of the CFR

(ii) The employer shall ensure that all medical evaluations and procedures including the hepatitis B vaccine and vaccination series and post-exposure evaluation and follow-up, including prophylaxis, are:

(A) Made available at no cost to the employee;

(B) Made available to the employee at a reasonable time and place;

(C) Performed by or under the supervision of a licensed physician or by or under the supervision of another licensed healthcare professional; and

(D) Provided according to recommendations of the U.S. Public Health Service current at the time these evaluations and procedures take place, except as specified by this paragraph (f).

(iii) The employer shall ensure that all laboratory tests are conducted by an accredited laboratory at no cost to the employee.

Subparagraph (D) is why a regulation that never mentions hepatitis C can still require testing for it: the clinical content is not in the standard but in whatever the Public Health Service currently recommends. That is why the rest of this page is mostly about four other documents, and why their publication dates matter more than the CFR's.

Two limits nearby are worth reading. The written opinion the evaluating professional gives the employer, under (f)(5)(ii), is confined to two facts: that the employee has been informed of the results, and that the employee has been told about any medical conditions resulting from the exposure that require further evaluation. Then (f)(5)(iii): "All other findings or diagnoses shall remain confidential and shall not be included in the written report."1

Washing and irrigation, and the number none of these documents contains

OSHA's washing duty is not in paragraph (f) at all. It sits in the work-practice controls, and it attaches to contact, whether or not anything is later reported.

29 CFR § 1910.1030(d)(2)(vi) · 2024 annual edition of the CFR

Employers shall ensure that employees wash hands and any other skin with soap and water, or flush mucous membranes with water immediately or as soon as feasible following contact of such body areas with blood or other potentially infectious materials.

NIOSH's page for healthcare workers, last reviewed 13 February 2025, is the only document in this set that names the eye separately from other mucous membranes and names a fluid.

NIOSH · Bloodborne Infectious Disease Risk Factors · cdc.gov, retrieved 2026-08-06

Wash needlestick or sharp punctures and cuts with soap and water.

Flush splashes to the nose, mouth, or skin with water.

Irrigate eyes with clean water, saline, or sterile irrigants.

Report the incident to your supervisor.

Immediately seek medical care to determine risk associated with the exposure.

CDC's 2013 hepatitis B guidance carries the same instruction in older Public Health Service wording, and adds what the evidence does not support: "Wounds and skin sites that have been in contact with blood or body fluids should be washed with soap and water; mucous membranes should be flushed with water. Using antiseptics (e.g., 2%–4% chlorhexidine) for wound care or expressing fluid by squeezing the wound further have not been shown to reduce the risk for HBV transmission; however, the use of antiseptics is not contraindicated."7 That paragraph descends almost verbatim from the 2001 Public Health Service guidelines, where it appears under the heading "Treatment of an Exposure Site".12

We found no statement of duration in any of them. Not one of these four documents says how many minutes to irrigate, how much fluid to use, or at what temperature. The fifteen-minute figure that circulates on exposure posters is not in the bloodborne pathogens standard, not on NIOSH's page, and not in the CDC guidance we retrieved. We did not trace where it comes from, and we are not saying it is wrong. What we can show is that the OSHA provision on drenching and flushing facilities, 29 CFR 1910.151(c), is triggered by a different hazard: "Where the eyes or body of any person may be exposed to injurious corrosive materials, suitable facilities for quick drenching or flushing of the eyes and body shall be provided within the work area for immediate emergency use."3 The only eyewash requirement inside the bloodborne pathogens standard is at (e)(3)(i) and (e)(4)(iii), and paragraph (e) governs HIV and HBV research laboratories and production facilities — not an operating room.1

Testing: what each guideline sets out

Three documents cover the three pathogens, written eleven years apart. The 2025 guidelines cover HIV and say expressly that recommendations on occupational exposures to hepatitis B and hepatitis C "have been published previously" and "are not included in these guidelines".4 Every schedule below is conditional in its own source. The table reproduces the operative phrases; the conditions stay in the documents.

Table 1. Post-exposure testing of the exposed worker, as stated in each retrieved federal guideline.
PathogenDocumentBaselineFollow-up
HIV 2025 US Public Health Service guidelines, published 15 September 2025 Perform baseline laboratory tests of exposed HCP as soon as possible after exposure, including: A rapid or lab-based fourth-generation HIV Ag/Ab combination immunoassay, and Serum creatinine, aspartate transaminase (AST) and alanine transaminase (ALT). Perform final HIV tests of exposed HCP using lab-based HIV Ag/Ab combination immunoassay and NAT at week 12 post-exposure. Interim tests at weeks 4–6 only for exposed HCP who initiated PEP more than 24 hours after a single exposure or who missed any PEP doses.
Hepatitis C CDC guidance, MMWR Recommendations and Reports, 24 July 2020 For HCP, baseline testing for anti-HCV with reflex to a NAT for HCV RNA if positive should be conducted as soon as possible (preferably within 48 hours) after the exposure and may be simultaneous with source-patient testing. HCP should be tested with a NAT for HCV RNA at 3–6 weeks postexposure. If HCV RNA is negative at 3–6 weeks postexposure, a final test for anti-HCV at 4–6 months postexposure is recommended.
Hepatitis B CDC guidance, MMWR Recommendations and Reports, 20 December 2013 HCP who have anti-HBs <10mIU/mL, or who are unvaccinated or incompletely vaccinated, and sustain an exposure to a source patient who is HBsAg-positive or has unknown HBsAg status, should undergo baseline testing for HBV infection as soon as possible after exposure and follow-up testing approximately 6 months later. Initial baseline tests consist of total anti-HBc; testing at approximately 6 months consists of HBsAg and total anti-HBc.

Source: sources 4, 6 and 7, each retrieved 2026-08-06 and transcribed from the document. Quoted fragments are verbatim; the column headings are ours. Each row omits conditions its own document attaches, and the hepatitis B row is one line of a five-row management table keyed to vaccination and response status. Read the documents before relying on any cell.

Source-patient testing is a duty in the standard itself. Under (f)(3)(ii)(A) the source individual's blood "shall be tested as soon as feasible and after consent is obtained in order to determine HBV and HIV infectivity", and under (f)(3)(ii)(C) the results "shall be made available to the exposed employee".1 Hepatitis C is absent from that sentence; the 2020 CDC guidance fills the gap by way of (f)(1)(ii)(D). Where the source cannot be tested, the hepatitis B guidance states the default: "When a source patient is unknown (e.g., as occurs from a puncture with a needle in the trash), the exposed HCP should be managed as if the source patient were HBsAg-positive."7

Prophylaxis, and two statements about 72 hours that are not the same statement

The occupational HIV guideline was replaced in September 2025. Its abstract says it updates the 2013 document, and that what changed includes "new antiretroviral drug regimens for post-exposure prophylaxis (PEP)" and "a shortened duration of post-exposure follow-up HIV testing".4 A page still reproducing the 2013 schedule of baseline, six weeks, twelve weeks and six months is reproducing a superseded document.5

2025 US Public Health Service Guidelines · Summary of recommendations, retrieved 2026-08-06

Educate HCP to report occupational exposures to blood and body fluids as soon as possible to their occupational health service.

Initiate PEP as soon as possible, up to 72 hours following the occupational exposure to HIV.

When considering initiation of PEP after 72 hours following occupational exposures thought to represent a high risk of transmission, consult a provider with expertise in HIV treatment (see Box 1).

Prescribe PEP regimens for a duration of 28 days.

Do not delay administration of PEP while waiting for information regarding the source patient's HIV status.

Re-evaluate exposed HCP within 72 hours after occupational exposure to assess for further counseling needs and PEP tolerability.

Those are three different uses of one number. Seventy-two hours is the outer edge of the recommended window for starting prophylaxis; it is also a trigger for expert consultation rather than a wall, since the same summary contemplates starting later in high-risk exposures; and it is separately the interval within which the exposed worker should be re-evaluated. On the underlying question the guideline is candid: "The precise interval after which no benefit is gained from PEP is uncertain for humans."4

A fourth use lives on a different CDC page. "PEP is not recommended >72 hours after exposure" appears on CDC's clinical guidance for PEP, whose opening paragraph defines its subject as nonoccupational prophylaxis and which was last reviewed 10 February 2025.9 It is a real sentence in a real federal document about a different population, and it is not the occupational recommendation. For hepatitis C, prophylaxis is addressed and declined: "Postexposure prophylaxis of hepatitis C is not recommended for HCP who have occupational exposure to blood and other body fluids."6 For hepatitis B it depends on vaccination and antibody status, and the guidance notes that the effectiveness of hepatitis B immune globulin given more than seven days after exposure is unknown.7

Four things the bloodborne pathogens standard does not contain

Reading a regulation for what is missing is as informative as reading it for what is there, and it is checkable. We scanned the codified text ourselves.

Table 2. Keyword scan of the codified text of 29 CFR 1910.1030, including its Appendix A.
TermOccurrences
hepatitis C0
HCV0
irrigat-0
drug test0
occupational health0
emergency room / emergency department0
eye wash / eyewash2
hepatitis B28
HIV29

Source: full codified text of § 1910.1030 as published in the 2024 annual edition of the CFR, retrieved as GPO XML from govinfo.gov on 2026-08-06, markup removed, 50,655 characters, case-insensitive regular-expression scan.1 Both “eye wash” hits are in paragraph (e), which governs HIV and HBV research laboratories and production facilities. The same text was compared against the text OSHA publishes on its own site and the two agree.2

The absence with the most practical weight is hepatitis C, carried entirely by the incorporation clause in (f)(1)(ii)(D). The absence readers ask about most often is different: the standard says nothing about drug or alcohol testing after an exposure, in either direction. That is an absence in the federal standard and nothing more — not a statement about what a facility may lawfully do or what a state requires.

Who the published documents say to call

Box 1 of the 2025 guidelines lists resources for expert consultation, and the first healthcare one is the "National Clinician Consultation Center (UCSF) Post-Exposure Prophylaxis Hotline at 888-448-4911".4 NIOSH prints the same number: "Call the Clinicians' Post Exposure Prophylaxis Line at 1-888-448-4911 if you have questions about medical treatment."8 So does CDC's HIV Nexus page.9

The Center's own PEP page, retrieved the same day, prints a different number and no 888 number at all: "Call for a Phone Consultation: 844-ASK-NCCC or 844-275-6222", with hours of 7 a.m. to 5 p.m. Pacific on weekdays and 10 a.m. to 2 p.m. at weekends.10 We report that as a discrepancy between published pages and nothing further: we did not telephone either number and cannot say whether the older one still routes, or which page is out of date. All of these pages describe a service for clinicians, not a line for a patient.

The documents do agree on the first step, and it is the step the forum threads show people skipping. NIOSH: "Report the incident to your supervisor." The 2025 guidelines: report "as soon as possible to their occupational health service." OSHA's duty in (f)(3) does not begin until a report exists.148

The splash nobody noticed

All of the above assumes the exposed person knows something happened. In the one series we retrieved that measured this directly, most did not. Four surgeons and their assistants wore 331 protective eye shields across 131 oculofacial plastic surgery cases; the shields were tested afterwards with a luminol blood-detection system and participants were questioned after each case. Blood was detected on 61% of the shields and in 80% of cases, "only 2% of blood splatters were recognized intraoperatively by the surgical participants", and splatter rates varied between individual surgeons from 29% to 90%.11

That is one study, in one subspecialty, at three sites, with four operating surgeons. It may mean unrecognised ocular contact is common in other settings; it does not establish it, and the certainty is low. The frequency question is handled separately in our article on operating-room exposure data.

What we could not retrieve, and where these documents differ

We did not obtain the professional-association guidance many facility protocols cite alongside the federal documents: those texts are copyrighted and sold, and this publication does not quote what it cannot show you. This page is the set of federal documents we could retrieve in full, not the complete set of published guidance.

The differences we can demonstrate are of scope and vintage rather than disagreements about care: the HIV guideline was rewritten in 2025 and the hepatitis documents were not; the hepatitis C schedule runs to 4–6 months while the HIV schedule now ends at week 12; the standard's source-testing sentence names two viruses where current guidance addresses three. We are not asserting a conflict between these documents about what should be done for a person.

What would change this answer

  • A revision of the hepatitis B or hepatitis C guidance. Either could be replaced without a word of the CFR changing, because (f)(1)(ii)(D) points at whatever the Public Health Service currently recommends.
  • An OSHA rulemaking or letter of interpretation addressing eye irrigation. Today the standard's only washing sentence is (d)(2)(vi), and its eyewash provisions reach research laboratories and production facilities.
  • Your State Plan. Twenty-nine states and territories run their own occupational safety programmes and may impose more than the federal text quoted here. We have not surveyed them.
  • A published resolution of the consultation-number discrepancy — either page updating, or the Center stating which line is current.
  • The open question in the literature: what proportion of ocular exposures in general surgical practice go unrecognised. We found no US multi-specialty study measuring it.

Where this could be wrong

The strongest objection is that a citational brief can mislead by omission. By declining to assemble a sequence we hand the reader documents with different scopes, vintages and conditional structures, and a reader in distress may take a quoted fragment for a rule that applies to them when its own document attaches conditions we did not reproduce. We think that risk is smaller than publishing a synthesised protocol under a byline that has never managed an exposure — but it is a real trade, and we are naming it.

Two narrower risks. The keyword scan proves an absence in one text, the codified section as published in the 2024 annual edition; that is not an absence in OSHA's compliance directives, in State Plan standards, or in any professional guideline. And guidance moves: the 2013 HIV document was current for twelve years and is now superseded, which is the failure this page warns about. If you are reading long after the review date above, check the documents themselves.

Sources

  1. Occupational Safety and Health Administration. Bloodborne pathogens. 29 CFR § 1910.1030. Codified text, 2024 annual edition of the Code of Federal Regulations, retrieved as GPO XML. https://www.govinfo.gov/content/pkg/CFR-2024-title29-vol6/xml/CFR-2024-title29-vol6-sec1910-1030.xml (accessed 2026-08-06).
  2. Occupational Safety and Health Administration. 1910.1030 — Bloodborne pathogens. Agency-published text of the same section, used to verify the transcription above. https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030 (accessed 2026-08-06). Archived copy: Internet Archive capture, 2026-08-01.
  3. Occupational Safety and Health Administration. Medical services and first aid. 29 CFR § 1910.151. Codified text, 2024 annual edition, retrieved as GPO XML. https://www.govinfo.gov/content/pkg/CFR-2024-title29-vol5/xml/CFR-2024-title29-vol5-sec1910-151.xml (accessed 2026-08-06).
  4. Kofman AD, Struble KA, Heneine W, et al. 2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings. Infection Control & Hospital Epidemiology. 2025;46(9):863–873. doi:10.1017/ice.2025.10254. https://pmc.ncbi.nlm.nih.gov/articles/PMC12616222/ (accessed 2026-08-06).
  5. Kuhar DT, Henderson DK, Struble KA, et al. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis. 2013. Superseded by source 4. Cited here for what it said and for the fact of its replacement. https://stacks.cdc.gov/view/cdc/20711/cdc_20711_DS1.pdf (accessed 2026-08-06). Archived copy: Internet Archive capture, 2026-01-03.
  6. Moorman AC, de Perio MA, Goldschmidt R, et al. Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020. MMWR Recommendations and Reports. 2020;69(6):1–8. Published 24 July 2020. https://www.cdc.gov/mmwr/volumes/69/rr/pdfs/rr6906a1-H.pdf (accessed 2026-08-06). Archived copy: Internet Archive capture, 2026-07-26.
  7. Schillie S, Murphy TV, Sawyer M, et al. CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. MMWR Recommendations and Reports. 2013;62(10):1–19. Published 20 December 2013. https://www.cdc.gov/mmwr/pdf/rr/rr6210.pdf (accessed 2026-08-06). Archived copy: Internet Archive capture, 2026-07-25.
  8. National Institute for Occupational Safety and Health. Bloodborne Infectious Disease Risk Factors. Page dated 13 February 2025. https://www.cdc.gov/niosh/healthcare/risk-factors/bloodborne-infectious-diseases.html (accessed 2026-08-06). Archived copy: Internet Archive capture, 2026-07-25.
  9. Centers for Disease Control and Prevention. Clinical Guidance for PEP. HIV Nexus. Page reviewed 10 February 2025. https://www.cdc.gov/hivnexus/hcp/pep/index.html (accessed 2026-08-06). Archived copy: Internet Archive capture, 2026-07-31.
  10. National Clinician Consultation Center, University of California, San Francisco. PEP: Post-Exposure Prophylaxis. https://nccc.ucsf.edu/clinician-consultation/pep-post-exposure-prophylaxis/ (accessed 2026-08-06). Archived copy: Internet Archive capture, 2026-06-25.
  11. Stacey AW, Czyz CN, Kondapalli SS, et al. Risk of ocular blood splatter during oculofacial plastic surgery. Ophthalmic Plastic and Reconstructive Surgery. 2015;31(3):182–186. PMID 25126769. https://pubmed.ncbi.nlm.nih.gov/25126769/ (accessed 2026-08-06).
  12. U.S. Public Health Service. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recommendations and Reports. 2001;50(RR-11). Superseded for HIV by source 4, for hepatitis C by source 6, and for hepatitis B by source 7. Cited only as the origin of the exposure-site wording. https://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf (accessed 2026-08-06). Archived copy: Internet Archive capture, 2026-07-25.

Further reading

  • Healthcare Infection Control Practices Advisory Committee meeting materials, which record the public review the 2025 guidelines went through before publication.
  • The OSHA compliance directive for the bloodborne pathogens standard, CPL 02-02-069, for how the agency instructs its own inspectors to read paragraph (f).
  • CDC's hepatitis B and hepatitis C infection-control pages for health care personnel, which restate sources 6 and 7 in shorter form for a clinical audience.

Claims ledger entries this article depends on

None. No claim on this page rests on a figure traced in the claims ledger; every assertion here is quoted from a document named in Sources and dated at the point of use. The nearest ledger material concerns figures in the surgical-waste business case, which this article does not touch.

About this article

Written by Zane Hitchcox, publisher. Not clinically reviewed. How we work, and where it could be wrong, is at Method. No financial relationship with any manufacturer, distributor, waste contractor or trade body.

Revision history

  • 1.0 — 2026-08-06 — First publication.

How to cite this page

Hitchcox Z. What published guidance says happens after a blood or body-fluid splash to the eye. The Operative Sentence. 2026-08-06. https://biodrainmedical.com/after-a-splash-to-the-eye/ (accessed YYYY-MM-DD).

Our prose, tables and diagrams are CC BY 4.0. Quoted government text is public-domain; third-party quotations remain their authors'.